# LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.

Study · id `cardio:ct-nct04790344` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04790344](<https://clinicaltrials.gov/study/NCT04790344>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04790344

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 557 participants.

## Technical summary

Registry record NCT04790344. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-03-20 (actual); primary completion 2026-07-27 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 557 participants (enrolled count; ClinicalTrials.gov record NCT04790344, source copy `cardio:ctgov-nct04790344-2026-11-16`, retrieved 2026-11-18)
- Started: 2021-03-20 (actual) (ClinicalTrials.gov record NCT04790344, source copy `cardio:ctgov-nct04790344-2026-11-16`, retrieved 2026-11-18)
- Primary completion: 2026-07-27 (actual) (ClinicalTrials.gov record NCT04790344, source copy `cardio:ctgov-nct04790344-2026-11-16`, retrieved 2026-11-18)
- Completion: 2026-07-27 (actual) (ClinicalTrials.gov record NCT04790344, source copy `cardio:ctgov-nct04790344-2026-11-16`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT04790344, source copy `cardio:ctgov-nct04790344-2026-11-16`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04790344-2026-11-16`, retrieved 2026-11-18)

## The registry's words

- Brief title: LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.
- Condition: Heart Failure
- Intervention (Device): Investigational LUX-Dx ICM Implant
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: cef36db8cddc09d2916e81388e705196ced2fdf66c7192edf3940261aa9a89e8
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
